Trademark: 97139421
Word
VALTED SEQ
Status Date
Thursday, April 11, 2024
Filing Date
Tuesday, November 23, 2021
Published for Opposition
Tuesday, August 22, 2023
44 Medical testing services, namely, next generation sequencing tests for diagnosis, prognosis, and treatment of brain cancer and brain tumors; Medical testing services, namely, immunoassays, enzyme-linked immunosorbent (ELISA) assays for disease detection
Nov 26, 2021
New Application Entered
Nov 29, 2021
New Application Office Supplied Data Entered
Sep 3, 2022
Assigned To Examiner
Sep 12, 2022
Non-Final Action Written
Sep 12, 2022
Non-Final Action E-Mailed
Sep 12, 2022
Notification Of Non-Final Action E-Mailed
Mar 6, 2023
Teas Response To Office Action Received
Jul 3, 2023
Assigned To Lie
Jul 3, 2023
Correspondence Received In Law Office
Jul 3, 2023
Teas/Email Correspondence Entered
Jul 17, 2023
Approved For Pub - Principal Register
Aug 22, 2023
Official Gazette Publication Confirmation E-Mailed
Aug 2, 2023
Notification Of Notice Of Publication E-Mailed
Aug 22, 2023
Published For Opposition
Apr 11, 2024
Sou Extension 1 Granted
Oct 17, 2023
Noa E-Mailed - Sou Required From Applicant
Apr 11, 2024
Sou Teas Extension Received
Apr 11, 2024
Sou Extension 1 Filed
Apr 12, 2024
Notice Of Approval Of Extension Request E-Mailed
Trademark Alertz updated from USPTO on 2030-01-24
